Davies A J, Belpomme D, Mathé G
Lancet. 1977 Mar 12;1(8011):555-8. doi: 10.1016/s0140-6736(77)91994-8.
50 cases of primary acute lymphoid leukaemia (A.L.L.) were analysed for the presence of T and B membrane markers on bone-marrow and/or peripheral-blood cells. 26% of cases were predominantly T-cell in type, 4% were B, the remaining 70%, without detectable membrane markers, were classified as "null" cell A.L.L. Of particular interest is the correlation between this immunological classification and the prognosis, since T-cell and B-cell A.L.L. were associated with a poorer prognosis than null-cell A.L.L. in terms of both median length of first complete remission and median survival. With one exception the T-cell cases were, according to the W.H.O. classification, of either the prolymphocytic or macrolymphoblastic type of A.L.L. and were more extensive than the comparable null-cell A.L.L. In contrast, cases of the W.H.O. prolymphoblastic and microlymphoblastic types were all found to be null-cell A.L.L. and were associated with the worst and best prognosis respectively. The correlation found between the immunological classification of A.L.L. and the prognosis means that patients with a poor prognosis can be selected for more intensive therapy.
对50例原发性急性淋巴细胞白血病(A.L.L.)患者的骨髓和/或外周血细胞进行了T和B膜标志物检测分析。26%的病例主要为T细胞型,4%为B细胞型,其余70%未检测到膜标志物,被归类为“无标记”细胞型A.L.L.。特别值得关注的是这种免疫分类与预后之间的相关性,因为就首次完全缓解的中位时长和中位生存期而言,T细胞型和B细胞型A.L.L.的预后比无标记细胞型A.L.L.更差。根据世界卫生组织(W.H.O.)的分类,除1例例外,T细胞型病例均为幼淋巴细胞性或大淋巴细胞母细胞性A.L.L.,且比相应的无标记细胞型A.L.L.病情更严重。相比之下,世界卫生组织分类中的幼淋巴细胞母细胞性和小淋巴细胞母细胞性类型的病例均为无标记细胞型A.L.L.,且分别与最差和最佳预后相关。A.L.L.免疫分类与预后之间的相关性意味着可以选择预后较差的患者进行更强化的治疗。